Evidence map›Paper›PMID 33962461›Full record

ArticleAdvances in nutrition (Bethesda, Md.)2021

Perspective: Framework for Developing Recommended Intakes of Bioactive Dietary Substances.

Allison A Yates, Johanna T Dwyer, John W Erdman, Janet C King, Barbara J Lyle, Barbara O Schneeman, Connie M Weaver, serving as an ad hoc Working Group on a Framework for Developing Recommended Intakes for Dietary Bioactives

Abstract read
In one paragraph

Article in Advances in nutrition (Bethesda, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Approach to personalizing the treatment of osteoporosis.The Journal of clinical endocrinology and metabolism · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Dietary Supplements Use among Serbian Undergraduate Students of Different Academic Fields.International journal of environmental research and public health · 2022
    Article
  15. Bioactives in the Food Supply: Effects on CVD Health.Current atherosclerosis reports · 2022
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Allison A YatesAgricultural Research Service/USDA (Retired), Johnson City, TN, USA.
Johanna T DwyerDepartment of Medicine, Tufts University School of Medicine and Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Tufts Medical Center, Boston MA, USA.
John W ErdmanDepartment of Food Science and Human Nutrition, University of Illinois, Urbana, IL, USA.
Janet C KingDepartment of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, USA.
Barbara J LyleB Lyle, Inc., Deerfield, IL, USA.ORCID 0000-0002-0362-7736
Barbara O SchneemanDepartment of Nutrition, University of California, Davis, CA, USA.
Connie M WeaverWeaver & Associates Consulting, LLC, Colorado Springs, CO, USA.
serving as an ad hoc Working Group on a Framework for Developing Recommended Intakes for Dietary Bioactives

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dietary bioactives are food substances that promote health but are not essential to prevent typical deficiency conditions. Examples include lutein and zeaxanthin, omega-3 fatty acids, and flavonoids. When quality evidence is available, quantified intake recommendations linking dietary bioactives with specific health benefits will enable health professionals to provide evidence-based information to consumers. Without evidence-based recommendations, consumers use information from available sources that often lack standards and rigor. This article describes a framework to develop guidance based on quality evidence fully vetted for efficacy and safety by qualified experts, and designed to communicate the amounts of specific dietary bioactive compounds with identified health benefits. The 4-step Framework described here can be adapted by credible health organizations to work within their guideline development process. Standards of practice used in clinical guidelines are adapted to quantify dietary bioactive intake recommendations from foods consumed by the general public, by taking into account that side effects and trade-offs are often needed for medical treatments but are not acceptable for dietary bioactives. In quantifying dietary bioactive recommendations, this Framework establishes 4 decision-making steps: 1) characterize the bioactive, determine amounts in specific food sources, and quantify intakes; 2) evaluate safety; 3) quantify the causal relation between the specific bioactive and accepted markers of health or normal function via systematic evidence reviews; and 4) translate the evidence into a quantified bioactive intake statement. This Framework provides a working model that can be updated as new approaches are advanced.

Indexed as

DietHealth PromotionFoodHumansLuteinZeaxanthinsLuteinZeaxanthinsdiet and healthdietary bioactivesdietary reference intakesdietary supplementsfood sourcesrecommended intakesreference valuessystems for nutrition evidence reviews

Identifiers

PMID33962461
PMCPMC8321833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.